R&D Systems™ Recombinant Human Coagulation Factor IX Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human Coagulation Factor IX Protein is derived from HEK293. The Recombinant Human Coagulation Factor IX Protein has been validated for the following applications: Enzyme Activity.

Order Info

Ships at ambient temperature.

Specifications

• Accession Number: P00740
• For Use With (Application): Enzyme Activity
• Formulation: Supplied as a 0.2μm filtered solution in Tris and NaCl.
• Gene ID (Entrez): 2158
• Molecular Weight (g/mol): 75 kDa
• Quantity: 20μg
• Source: Human embryonic kidney cell,HEK293-derived human Coagulation Factor IX protein Thr29-Thr461,with a C-terminal Fc tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
• Regulatory Status: RUO
• Endotoxin Concentration: <1.0 EU per 1μg of the protein by the LAL method
• Gene Alias: Christmas factor, coagulation factor IX, EC 3.4.21, EC 3.4.21.22, F9
• Biological Activity: >30 pmol/min/µg
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.

For Research Use Only.